A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated
Open Access
- 20 January 2004
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (2) , 359-365
- https://doi.org/10.1038/sj.bjc.6601526
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trialLung Cancer, 2002
- Economic Analysis of Vinorelbine Plus Cisplatin Versus Paclitaxel Plus Carboplatin for Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Interim analysis of a phase II study of induction weekly paclitaxel/carboplatin regimens followed by maintenance weekly paclitaxel for advanced and metastatic non-small cell lung cancerSeminars in Oncology, 2001
- Weekly paclitaxel in advanced non[ndash ]small cell lung cancerSeminars in Oncology, 2001
- A Phase II Trial of Vinorelbine and Cisplatin in Previously Untreated Inoperable Non—Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 2000
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced nonsmal cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995